Last reviewed · How we verify
NCT06349434
The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI
NA trial testing MyoMo in SCI - Spinal Cord Injury in 60 participants. Currently enrolling.
1 October 2028
Quick facts
| Lead sponsor | Kessler Foundation |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 15 October 2023 |
| Primary completion | 1 October 2028 |
| Estimated completion | 1 October 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MyoMo
- conventional therapy — full drug profile →
Conditions studied
- SCI - Spinal Cord Injury — all drugs for SCI - Spinal Cord Injury →
- Upper Extremity Dysfunction — all drugs for Upper Extremity Dysfunction →
- Upper Extremity Problem — all drugs for Upper Extremity Problem →
Sponsor
Kessler Foundation
Who can join
Adults 18 to 80, any sex, with SCI - Spinal Cord Injury or Upper Extremity Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the usefulness of an upper extremity assistive device, called (MyoPro) in improving upper extremity activities in people with incomplete spinal cord injury. The Department of Defense is supporting this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06349434
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MyoMo
Trials testing the same drug.
- NCT04855812 — The Efficacy of Upper Extremity Wearable Robotic Orthosis on Improving Upper Extremity Motor Function and Activities of · NA · completed
Other recruiting trials for SCI - Spinal Cord Injury
Currently open trials in the same condition.
- NCT07179588 — Nutrition and Pain Study · NA · active not recruiting
- NCT07052344 — Gut-Brain Neural Coupling in Spinal Cord Injury · NA · recruiting
- NCT05630235 — Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI · Phase 1, PHASE2 · recruiting
- NCT06999434 — Exploring the Utility of [18F]3F4AP for Demyelination Imaging · Phase 1 · recruiting
- NCT07106060 — Near-Infrared Imaging of Motor Imagery Effects in Spinal Cord Injury · NA · recruiting
Other Kessler Foundation trials
Trials by the same sponsor.
- NCT07168941 — Evaluation and Refinement of KF-STRIDE Into the Interview! · NA · not yet recruiting
- NCT07159100 — tDCS for Cancer-Related Fatigue and Weakness · EARLY_PHASE1 · not yet recruiting
- NCT07073313 — Using Muscle Functional MRI to Study Spatial Muscle Activation Patterns in People With SCI · not yet recruiting
- NCT06886152 — Spinal Stimulation and Gait Training to Improve Mobility in TBI · NA · not yet recruiting
- NCT06923293 — Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06349434 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kessler Foundation
- Last refreshed: 24 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06349434.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing